KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Goodwill (2019 - 2025)

Historic Goodwill for Biolife Solutions (BLFS) over the last 7 years, with Q3 2025 value amounting to $212.3 million.

  • Biolife Solutions' Goodwill fell 553.39% to $212.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $212.3 million, marking a year-over-year decrease of 553.39%. This contributed to the annual value of $212.3 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Biolife Solutions reported Goodwill of $212.3 million as of Q3 2025, which was down 553.39% from $212.3 million recorded in Q2 2025.
  • Biolife Solutions' 5-year Goodwill high stood at $224.7 million for Q1 2022, and its period low was $58.4 million during Q1 2021.
  • Moreover, its 5-year median value for Goodwill was $224.7 million (2022), whereas its average is $202.4 million.
  • As far as peak fluctuations go, Biolife Solutions' Goodwill surged by 56834.6% in 2021, and later tumbled by 553.39% in 2023.
  • Over the past 5 years, Biolife Solutions' Goodwill (Quarter) stood at $58.4 million in 2021, then skyrocketed by 284.51% to $224.7 million in 2022, then dropped by 5.53% to $212.3 million in 2023, then changed by 0.0% to $212.3 million in 2024, then changed by 0.0% to $212.3 million in 2025.
  • Its Goodwill stands at $212.3 million for Q3 2025, versus $212.3 million for Q2 2025 and $212.3 million for Q1 2025.